AbCellera Biologics Inc.ABCLNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-11.6%
5Y CAGR-60.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-11.6%/yr
Annual compound
5Y CAGR
-60.5%/yr
Recent acceleration
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 6.89% |
| 2024 | -54.02% |
| 2023 | -159.30% |
| 2022 | 9.98% |
| 2021 | 2221.72% |
| 2020 | 715.27% |
| 2019 | 25.20% |
| 2018 | 0.00% |